American Healthcare REIT, Inc. research snapshot
AHR AI stock analysis currently reads American Healthcare REIT as a diversified healthcare REIT with senior housing operating (SHOP), integrated senior health campuses (ISHC), outpatient medical, and triple-net leased assets. At the July 12, 2026 cutoff, the latest verified close used here was $53.57, and Nasdaq market capitalization was about $10.32 billion. Q1 2026 total revenues were $650.8 million, NFFO was $0.50 per diluted share, total portfolio same-store NOI grew 12.1%, and full-year 2026 NFFO guidance was raised to $2.03 to $2.09. The main question is whether SHOP and ISHC growth, accretive acquisitions, and balance-sheet improvement can justify a price near 26x guided midpoint NFFO while the stock trades close to its 52-week high. This is informational research and not investment advice.
Current price
$53.57
Market cap
$10.32 billion
AI score
70 / 100
Rating
Growth healthcare REIT with strong same-store NOI and raised NFFO guidance, but a rich multiple and limited margin of safety near 52-week highs
Trend status
Near the top of the 52-week range, slightly below the recent 50-day average area, and still above the longer-term uptrend
Data cutoff (updated weekly)
July 12, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | AHR is paid to own and operate clinical healthcare real estate, primarily senior housing communities, integrated senior health campuses, outpatient medical buildings, and triple-net healthcare assets across the United States and limited international holdings. | High |
| Moat | The moat comes from operating relationships, the Trilogy ISHC platform, scale in senior housing operations, public capital access, and development capability. It is weaker than a monopoly moat because capital can compete for similar healthcare real estate when yields are attractive. | Medium |
| Management | Chairman Jeff Hanson is serving as interim CEO and president after Danny Prosky took medical leave. Capital allocation has emphasized SHOP acquisitions, ATM equity, lower net debt to EBITDA, and raised 2026 NFFO guidance. Key-person and transition risk remain active. | Medium |
| Financial trend | Q1 2026 total revenues were $650.8 million, net income attributable to controlling interest was $23.7 million ($0.13 per diluted share), NAREIT FFO was $0.48 per share, and NFFO was $0.50 per share. Same-store NOI grew 12.1%, and 2026 NFFO guidance was raised to $2.03 to $2.09. | High |
| Valuation | At $53.57, AHR traded near 26.0x midpoint 2026 NFFO guidance, about 27.3x midpoint NAREIT FFO, roughly 90.8x trailing GAAP earnings, about 2.9x book value, and a 1.87% dividend yield. The verified three-scenario model produced a base case near $54.0 and a bear case near $35.0. | Medium-high |
| Technical trend | AHR closed at $53.57 on July 10, 2026, near the top of its $35.70 to $55.75 52-week range. Short-term momentum is elevated, with the recent 50-day area near $54 and resistance at the $55.00 to $55.75 high zone. | Medium |
| Risk level | Risk is moderate to elevated for a REIT. Key risks are senior housing operating leverage, operator concentration, Medicaid and Medicare reimbursement, equity dilution from ATM and forward sales, interest rates, and interim CEO transition. | Medium-high |
| AI confidence | High for company-reported Q1 2026 income statement, NFFO, guidance, liquidity, and verified market-cap math; medium for future occupancy, labor costs, operator performance, and the durability of a premium NFFO multiple. | Medium-high data confidence |
| Investment certainty | Medium certainty. AHR has a clear growth algorithm in SHOP and ISHC, but the current price already discounts continued strong same-store growth and leaves limited margin of safety if growth slows or multiples compress. | Medium |
AHR AI stock forecast
The AHR AI stock forecast uses NFFO per share, FFO multiples, same-store NOI growth, occupancy and rate power in senior housing, acquisition spreads, equity issuance, leverage, dividend coverage, and technical trend rather than a single deterministic price prediction. The bullish case becomes more likely if 2026 NFFO guidance is raised again, SHOP and ISHC same-store growth stay double digit, acquisitions remain accretive, and the market holds a premium multiple. The bearish case becomes more likely if occupancy or labor costs worsen, equity dilution outpaces earnings growth, rates rise, or the market assigns a lower NFFO multiple.
$74 to $78
More likely if AHR compounds NFFO near 10% annually, the market applies a 28x terminal NFFO multiple, SHOP and ISHC keep delivering double-digit same-store growth, and acquisitions stay accretive after equity issuance. The verified three-scenario model produced about $76.8 using 10% growth and a 28x terminal multiple.
$52 to $56
More likely if AHR tracks the 2026 NFFO guidance midpoint near $2.06, same-store NOI growth stays near the raised 9% to 12% band, and the stock holds around a 22x NFFO multiple. The verified model base case was about $54.0.
$33 to $37
More likely if NFFO growth slows toward low single digits, senior housing margins compress, dilution rises, or AHR is valued closer to a 16x NFFO multiple. The verified bear model produced about $35.0.
AHR AI technical analysis
AHR AI technical analysis starts from the $53.57 close on July 10, 2026. The stock is near the top of its $35.70 to $55.75 52-week range, slightly below the recent 50-day average area near $54, and still above its longer-term uptrend according to multi-source chart context. Technical levels should be checked against Q2 2026 earnings, NFFO guidance updates, equity issuance headlines, rate moves, and senior housing operating data.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $53.57 | Latest verified close used for this page, reported for July 10, 2026 on Nasdaq historical data. |
| Near support | $52.50 to $53.00 | This zone covers the recent pullback lows around the July 10 session low near $52.49. Holding it keeps the short-term structure constructive. |
| Secondary support | $50.00 to $51.00 | This zone is a psychological round-number area and a watch level if the stock loses the recent 50-day zone. |
| Resistance | $55.00 to $55.75 | This area overlaps the 52-week high zone. A breakout would need volume and fundamental confirmation from NFFO growth or guidance. |
| 50-day moving average | Near $54.14 | Third-party technical snapshots placed the 50-day average near $54.14 around early July 2026. AHR was slightly below that area at the $53.57 close. |
| 200-day moving average | Below price (longer-term uptrend intact) | Multi-source chart context shows AHR trading above its 200-day average and near the top of the 52-week range. Exact print can differ by vendor and date. |
| Momentum | Elevated RSI near the mid-to-high 60s on multi-source snapshots | Momentum is positive but stretched after the rally toward the highs. Momentum still needs confirmation from volume and operating news. |
| Volume | About 1.76 million shares on the latest session; 3-month average near 3.2 million | A move above $55.00 would be more credible if volume expands rather than fading near resistance. |
| Volatility | Recent 14-day ATR near $1.66 | AHR can move more than a typical utility stock when REIT multiples reprice or equity offerings are announced. |
| Invalidation | Close below $50.00 or lower NFFO guide | A break below $50.00, weaker 2026 NFFO guidance, or clear senior housing margin pressure would weaken the base case. |
AHR AI trading strategy
The AHR AI trading strategy is a rules-based framework, not personalized advice. It should be monitored through live price, moving averages, Q2 2026 earnings, 2026 NFFO guidance, same-store NOI, occupancy and labor costs, acquisition volume, ATM equity issuance, net debt to EBITDA, and reimbursement news.
Track whether AHR holds the $52.50 to $53.00 area and then clears $55.00 to $55.75 with improving volume. Confirmation improves if Q2 2026 results keep NFFO guidance at $2.03 to $2.09 or raise it, and SHOP and ISHC same-store growth stay strong.
Reduce confidence if price closes below $52.50, if volume expands on down days, if REIT multiples compress on higher rates, or if equity offerings outpace acquisition accretion.
Use pullbacks toward the $50.00 to $51.00 support area as a watchlist condition only if same-store NOI, occupancy, and NFFO guidance remain intact.
Do not treat the dividend as a valuation floor. At about a 1.9% yield, income support is modest, so multiple compression can still dominate near-term returns.
Track NFFO per share, NAREIT FFO per share, same-store NOI by segment, SHOP occupancy and rate power, Trilogy ISHC results, acquisition yields, ATM and forward equity issuance, net debt to annualized adjusted EBITDA, and liquidity.
A mix of lower NFFO guidance, weaker same-store growth, faster dilution, higher financing costs, or a close below $50.00 would override a bullish chart setup.
Investment research summary
American Healthcare REIT is paid to provide real estate capital and operating platforms for senior housing, integrated senior health campuses, outpatient medical buildings, and triple-net healthcare facilities. Residents, patients, and tenants generate recurring fees and rents, while AHR converts property cash flows into NFFO, dividends, development, and acquisitions.
The moat is built from operating partnerships, the Trilogy integrated campus model, scale in senior housing operations, development know-how, and access to public equity and credit. The moat can narrow if capital costs rise faster than acquisition yields or if operator and labor pressure reduces same-store NOI growth.
The thesis can fail if senior housing occupancy falls, labor costs spike, reimbursement is cut, equity issuance dilutes per-share growth, interest rates reprice REIT multiples, the interim CEO transition weakens execution, or investors overpay for recent growth at a premium NFFO multiple.
Jeff Hanson is chairman and interim CEO after Danny Prosky took medical leave in early 2026. Recent capital allocation has favored SHOP acquisitions, ATM equity, credit-facility expansion, and lower leverage. The main test is whether per-share NFFO growth continues while leadership transition risk is still present.
The long-term trend is supported by aging demographics and demand for senior housing and post-acute care capacity. The near-term cycle depends on occupancy, private-pay pricing power, labor availability, reimbursement rates, and capital-market access for healthcare REITs.
The verified scenario model produced about $76.8 in the bull case, $54.0 in the base case, and $35.0 in the bear case using 2026 NFFO midpoint $2.06 as the earnings proxy. The margin of safety is limited because AHR trades near 26x guided NFFO and close to 52-week highs, not at a distressed multiple.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| AHR price | $53.57 close on July 10, 2026 | Nasdaq historical quote data | July 12, 2026 |
| Market capitalization | $10.32 billion on Nasdaq, verified as $53.57 x about 192.72 million shares | financial_rigor.py market cap verification and Nasdaq summary market cap | July 12, 2026 |
| Shares outstanding context | 189.94 million common shares outstanding as of March 31, 2026; later ATM settlements and vendor share counts differ (about 192.7M for Nasdaq market-cap math, up to about 206.7M on some third-party pages) | AHR Q1 2026 earnings release balance sheet and Nasdaq market cap math | July 12, 2026 |
| FY2025 and TTM revenue | FY2025 revenue about $2.26 billion; TTM revenue ending March 31, 2026 about $2.37 billion | Macrotrends revenue history | July 12, 2026 |
| Q1 2026 total revenues and net income | $650.8 million total revenues and $23.7 million net income attributable to controlling interest ($0.13 per diluted share) | AHR Q1 2026 results press release | July 12, 2026 |
| Q1 2026 FFO and NFFO | NAREIT FFO $90.4 million ($0.48 per diluted share) and Normalized FFO $94.8 million ($0.50 per diluted share) | AHR Q1 2026 results press release | July 12, 2026 |
| Q1 2026 same-store NOI growth | Total portfolio same-store NOI +12.1%; SHOP +19.7%; ISHC +14.5%; outpatient medical +1.6%; triple-net +4.6% | AHR Q1 2026 results press release | July 12, 2026 |
| Q1 2026 leverage and liquidity | Net debt to annualized adjusted EBITDA 3.0x, total consolidated indebtedness about $1.53 billion, and total liquidity about $1.31 billion including cash, undrawn credit capacity, and expected forward-sale proceeds | AHR Q1 2026 results press release | July 12, 2026 |
| 2026 NFFO and same-store guidance | NFFO $2.03 to $2.09 per diluted share (midpoint $2.06) and total portfolio same-store NOI growth 9.0% to 12.0% | AHR Q1 2026 results press release | July 12, 2026 |
| Dividend and valuation | $1.00 annualized dividend, about 1.87% yield, about 26.0x price to 2026 midpoint NFFO, about 90.8x trailing GAAP PE, and about 2.9x book value | Yahoo Finance key statistics context and financial_rigor.py valuation verification | July 12, 2026 |
| Technical indicators | 52-week range $35.70 to $55.75, recent 50-day average area near $54.14, latest session volume about 1.76 million, 3-month average volume near 3.2 million, recent 14-day ATR near $1.66 | Nasdaq quote data, Investing.com technical snapshot, and Yahoo volume context | July 12, 2026 |
| Three-scenario valuation model | Bull case $76.8, base case $54.0, bear case $35.0 based on 2% to 10% NFFO growth and 16x to 28x terminal multiples | financial_rigor.py three-scenario calculation | July 12, 2026 |
| Data source gap | Share-count definitions differ across Nasdaq market-cap math, company March 31 share count, and some third-party diluted or OP-unit-inclusive counts. Exact 200-day and RSI prints also differ by vendor. Operator-level margin and occupancy detail is mostly company-reported. | Cross-source share count and technical vendor comparison | July 12, 2026 |
This AHR AI stock analysis page is an informational tool only and is not investment advice, tax advice, or a recommendation to buy or sell any security. Forecast ranges are scenarios based on available public data as of July 12, 2026 and may be wrong if financial results, rates, reimbursement policy, senior housing operations, acquisition spreads, equity issuance, financing costs, dividend policy, management transition, or market conditions change.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
